From: Cost-utility analysis of a national project to reduce hypertension in Israel
Age/Sex | Hypertension (%) | AMI (20 y %risk) | CVA (rate/1000) | ESRD (rate/100,000) |
---|---|---|---|---|
25–44 M/F | 3.8/3.2 | 5–22 | 1.14 | NA |
45–54 M/F | 14.7/13.9 | 23–32 | 2.28 | 31.9/16.7 |
55–64 M/F | 34.5/27.8 | 33–50 | 5.11 | 77.8/44.6 |
65< | 50< | 50< | 9.86 | 148.7/88.5 |